US FDA May User Fee Preview: Vaccines, Gene Therapy, And Double Oncologics

RSV test
Moderna's RSV vaccine candidate has a 12 May user fee goal. • Source: Shutterstock
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

More from US FDA Performance Tracker

More from Regulatory Trackers